Latest Series C+ Funding Rounds

Later-stage rounds, from Series C onwards, for companies expanding products, distribution and operations.

This page showsStage: Series C+
Rounds
572
All time
Disclosed funding
$283.5B
494 disclosed amounts
Median round
$126M
Of disclosed amounts
572 rounds
Funding rounds
CompanyAmountRoundSectorCountryInvestorsAnnounced
BasetenAI · United StatesCompany profile

Builds systems software for AI applications, focusing on inference and model deployment

Builds systems software for AI applications, focusing on inference and model deployment

$300MSeries ESeries C+AIUnited StatesInvestors
MewsTravel tech · NetherlandsCompany profile

Mews provides hospitality software for revenue and operational workflows.

Mews provides hospitality software for revenue and operational workflows.

$300MSeries DSeries C+Travel techNetherlandsInvestors
LiveKitAI · United StatesCompany profile

Developer of infrastructure software for real-time AI voice and video applications

Developer of infrastructure software for real-time AI voice and video applications

$100MSeries CSeries C+AIUnited StatesInvestors
D-OrbitSpace tech · ItalyCompany profile

D-Orbit provides orbital transport, satellite deployment and infrastructure services for commercial and institutional space missions.

D-Orbit provides orbital transport, satellite deployment and infrastructure services for commercial and institutional space missions.

UndisclosedSeries D participation with secondary share purchasesSeries C+Space techItalyInvestors
ZBDMedia & gaming · United StatesCompany profile

Provides real-money payment infrastructure for games and apps

Provides real-money payment infrastructure for games and apps

$40MSeries CSeries C+Media & gamingUnited StatesInvestors
ClarotyCybersecurity · United StatesCompany profile

Provides cyber-physical systems protection platform

Provides cyber-physical systems protection platform

$150MSeries FSeries C+CybersecurityUnited StatesInvestors
Corxel PharmaceuticalsBiotech · ChinaCompany profile

Corxel Pharmaceuticals develops clinical-stage medicines for cardiometabolic diseases, including obesity, diabetes, stroke and hypertension.

Corxel Pharmaceuticals develops clinical-stage medicines for cardiometabolic diseases, including obesity, diabetes, stroke and hypertension.

≤$287MSeries D1Series C+BiotechChinaInvestors
DatarailsFintech · United StatesCompany profile

Datarails provides financial planning, analysis and cash-management software for finance teams.

Datarails provides financial planning, analysis and cash-management software for finance teams.

$70MSeries CSeries C+FintechUnited StatesInvestors
PreplyEdtech · United StatesCompany profile

Provides human-led, AI-enhanced language learning platform

Provides human-led, AI-enhanced language learning platform

$150MSeries DSeries C+EdtechUnited StatesInvestors
OpenEvidenceHealthtech · United StatesCompany profile

Provides AI-powered medical search engine for clinicians

Provides AI-powered medical search engine for clinicians

$250MSeries DSeries C+HealthtechUnited StatesInvestors

Active investors in this selection

All investors →

Ranked by rounds participated in · All time

  1. 1
    Andreessen Horowitz (a16z)

    Isomorphic Labs, Northwood Space, Kalshi

    44rounds
    5led
  2. 2
    General Catalyst

    Mercor, Clara, Nominal

    44rounds
    1led
  3. 3
    Sequoia Capital

    Isomorphic Labs, LangChain, Nominal

    43rounds
    8led
  4. 4
    Lightspeed

    Payhawk, Nominal, Fractile

    39rounds
    7led
  5. 5
    NVIDIA

    Agile Robots, Mercor, fal

    36rounds
    0led

Latest digests

Archive →

Explore published rounds while the next edition is being prepared.

Browse rounds by topic